UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-12537

 

 

NextGen Healthcare, Inc.

(Exact name of registrant as specified in its charter)

 

 

Not Applicable⁽¹⁾

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, Par Value $0.01 Per Share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

		Rule 12g-4(a)(1)		☒
		Rule 12g-4(a)(2)		☐
		Rule 12h-3(b)(1)(i)		☒
		Rule 12h-3(b)(1)(ii)		☐
		Rule 15d-6		☐
		Rule 15d-22(b)		☐

Approximate number of holders of record as of the certification or notice date: One (1)

Pursuant to the requirements of the Securities Exchange Act of 1934, NextGen Healthcare, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

				NEXTGEN HEALTHCARE, INC.
Date: November 20, 2023				By:		/s/ David Sides
				Name:		David Sides
				Title:		Chief Executive Officer

 

(1)

NextGen Healthcare, Inc. is a remote-first company and no longer maintains its principal executive office. For purposes of compliance with applicable requirements of the Securities Act of 1933, as amended, and Securities Exchange Act of 1934, as amended, stockholder communications required to be sent to our principal executive offices should be directed to the email address set forth in our proxy materials and/or identified on our investor relations website